HJA | VOLUME 9 | ISSUE 2 | APRIL – JUNE 2018

 

Letter to the Editor

PCSK9 administration ameliorates non alcoholic fatty disease in patients with heterozygous familial hyperlipidemia
A. Dimakopoulou, G. Sfikas, V. Athyros


Editorial
The role of lipid-lowering treatment in the secondary prevention of ischemic stroke
E. Konstantinidou, K. Tziomalos 


Original Articles
The effects of atorvastatin 30 mg compared with atorvastatin 40 mg in patients with primary hyperlipidemia: a multicenter study
C.V. Rizos, E.N. Liberopoulos, E. Mpilianou, V. Kotsis, N. Tentolouris, C. Antza, I. Eleftheriadou, V. Tsimihodimos, M.S. Elisaf


Cost-benefit analysis of mediterranean diet and medication in chronic heart failure patients
Ε. Tzorovili, C. Chrysohoou, E. Bei, K. Konstantinou, A. Filippou, S. Iosifidis 

Read Volume 9 here